Drug intelligence / Profile preview

BSL_EP024

Development stage: Unknown
Lead developer: Biosearch

Overview

BSL_EP024 is a proprietary combination of plant extracts characterized by a high content of phenolic compounds. Developed by the Spanish company Bioscience S.L., the formulation is designed to enhance and activate the immune response, potentially offering protection against infections. The product's activity is attributed to the synergistic effects of its constituent polyphenols, which are known for their immunomodulatory and antioxidant properties. BSL_EP024 has been studied in clinical settings, including a completed trial (NCT04029558) evaluating its impact on immunological parameters in healthy subjects.

Other names: Combination of plant extracts (BSL_EP024)

Beyond the preview

Go deeper on BSL_EP024.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BSL_EP024.

Explore the full profile